Fundz

SquareMind Raises $18 Million to Redefine Skin Exams With Robotics and AI. Led by Sonder Capital, this funding will help launch the Swan™ robotic platform in the U.S. and Europe.

PRIVATEApr 27, 2026

Amount Raised

$18 Million

Round Type

Series A

BiotechnologyHealth CareArtificial IntelligenceMedical Device

Investors

Deeptech 2030 FundAdamed TechnologyCalm/Storm VenturesTeampact VenturesSonder Capital

Description

SquareMind, an AI and robotics company, has announced $18 million in funding for its skin exam innovations. The round aims to support the growth of its teams in preparation for the launch of the Swan™ robotic imaging platform. Led by Sonder Capital, the funding also includes participation from several notable investors. This initiative addresses the increasing demand for skin exams among the aging population.

Quick answer

SquareMind raised $18 Million in a Series A round, dated April 27, 2026. Investors: Deeptech 2030 Fund, Adamed Technology, Calm/Storm Ventures, Teampact Ventures and Sonder Capital.

How much did SquareMind raise?
SquareMind raised $18 Million in a Series A round on April 27, 2026.
Who invested in SquareMind?
Deeptech 2030 Fund, Adamed Technology, Calm/Storm Ventures, Teampact Ventures and Sonder Capital are named as investors in this round.
What does SquareMind do?
SquareMind is a Paris-based AI and robotics company developing solutions for dermatology, whose mission is to make high-quality skin exams more efficient and accessible.
Where is SquareMind based and how big is it?
Fundz records about 17 employees.
Who are the decision-makers at SquareMind?
Fundz holds 1 contact at SquareMind, including the Co-Founder & CEO (hiring!). Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as SquareMind that raised within 45 days of this round, from Fundz verified event records.

  • Uncovr raised $7M (Seed) on June 10, 2026.
  • Bioxtreme raised $15M (Funding Round) on April 21, 2026.
  • ThruFlo Endovascular raised an undisclosed amount (Seed) on June 11, 2026.
  • FesariusTherapeutics raised $20M (Series A) on June 10, 2026.
  • NVENTRIC raised $23M on June 10, 2026.
  • Promedius raised $17M (Pre-Seed) on June 10, 2026.

Who to call at SquareMind, and when

A new round usually means SquareMind is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SquareMind raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SquareMind, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SquareMind. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SquareMind

About

SquareMind is a Paris-based AI and robotics company developing solutions for dermatology, whose mission is to make high-quality skin exams more efficient and accessible. The company works closely with leading dermatologists to develop world-class solutions that are redefining the standard of care. SquareMind's flagship product, Swan™, is the world's first robot designed for dermoscopic-level, full-body skin imaging. This technology supports dermatologists by automating routine procedures and optimizing clinical workflows.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SquareMind raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAli K., Co-Founder & CEO (hiring!) hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SquareMind's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

SquareMind raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.